Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05526404 · ClinicalTrials.gov registry record · NA
Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05526404: Completed NA study, sponsored by Mayo Clinic.
NCT05526404 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05526404, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.
Interventions
- OTHER Dieta mobile application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2023-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05526404
The ClinicalTrials.gov registry entry for NCT05526404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dieta mobile application is the first listed.
NCT05526404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05526404 about?
NCT05526404 is a clinical study titled "Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration". This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.
What is the current status of trial NCT05526404?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-14. Estimated completion is 2023-07-08.
What interventions are being tested in trial NCT05526404?
The interventions under investigation include: Dieta mobile application (OTHER).
Who is sponsoring clinical trial NCT05526404?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.